查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1933914

輸尿管支架系統市場（按材料、產品類型、適應症、最終用戶和分銷管道分類），全球預測，2026-2032年

Ureteral Stent System Market by Material, Product Type, Indication, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，輸尿管支架系統市場價值將達到 10.6 億美元，到 2026 年將成長至 11.5 億美元，到 2032 年將達到 18.4 億美元，年複合成長率為 8.16%。

關鍵市場統計數據
基準年 2025 10.6億美元
預計年份：2026年 11.5億美元
預測年份 2032 18.4億美元
複合年成長率 (%) 8.16%

權威深入分析了影響現代輸尿管支架系統決策的臨床重點、設備發展歷程和營運促進因素。

輸尿管支架系統在泌尿系統治療中繼續發揮至關重要的作用，它能夠引流上泌尿道積水，適用於多種適應症，包括阻塞性結石、惡性腫瘤壓迫以及良性狹窄。近年來，技術的進步使該領域從簡單的聚合物管發展到採用先進材料、表面處理和幾何設計的裝置，旨在提高患者舒適度、減少結石嵌頓並延長支架留置時間。臨床醫師和醫療系統管理者在評估支架選擇時，不僅關注其即時臨床療效，也越來越重視其對後續治療的影響，例如再入院率、再次手術率和總醫療成本。

材料科學、抗菌技術和不斷發展的醫療保健服務模式的進步如何重新定義輸尿管支架系統的臨床實踐和商業策略

輸尿管支架系統正經歷多重變革的重塑，這些變革涵蓋臨床、技術和組織等多個面向。材料科學的進步，例如可生物分解聚合物和表面光潔度更高的鎳鈦合金，正在催生新的產品類型，旨在減少結石沉積和移位等併發症。同時，藥物釋放型塗層和抗菌表面技術的進步正在應對感染和生物膜的風險，使臨床醫生能夠考慮將支架療法應用於更廣泛的適應症和更長的治療週期。此外，積層製造和精密工程技術的進步也為更個人化的支架幾何形狀和患者特異性解決方案開闢了道路，儘管監管和規模化生產仍然是實際操作中的限制因素。

新累積關稅對輸尿管支架生態系統中的採購、製造韌性和基本契約的營運和策略影響

美國新關稅的實施為輸尿管支架價值鏈帶來了複雜的挑戰，也促使各企業採取相應的策略應對措施。對關鍵原料和成品組件徵收的進口關稅增加了依賴全球供應商的製造商的在地採購成本，尤其是在特殊聚合物和金屬合金領域。為了應對這些挑戰，許多公司已啟動策略行動，例如重新談判供應合約、最佳化庫存以及選擇性地將關鍵生產投入轉移到近岸地區，以降低其受跨境關稅波動的影響。然而，這些舉措需要前期投資和時間來檢驗新製造地的品質系統和合規性。

透過深度細分分析，將終端用戶、材料創新、設備分類、臨床適應症和通路與策略商業化決策聯繫起來。

深入了解輸尿管支架市場的臨床和商業性細分對於推動產品開發和市場推廣策略至關重要。從終端使用者角度分析，此市場可分為門診手術中心、診所和醫院。在門診手術中心內部，醫院所有和醫生所有機構各有其特點；而在醫院內部，私立和公立機構的採購模式也存在差異。從材料角度來看，產品類別包括可生物分解材料（如聚己內酯和PLGA）、鎳鈦合金或不銹鋼合金製成的金屬支架，以及基於PVC或矽膠的聚合物支架。每種材料在生物相容性、柔軟性、滲透性和製造程序複雜性方面各有優缺點。

區域法規環境、報銷趨勢和醫療服務趨勢將如何影響美洲、歐洲、中東和非洲以及亞太地區的醫療服務普及和獲取

區域趨勢對全球輸尿管支架系統的法規結構、報銷機制和臨床應用模式有顯著影響。在美洲，多樣化的支付方結構和眾多三級醫療中心推動了對差異化器械功能和循證醫學證據的需求，這些需求使得較高的單價在後續干預減少的情況下具有合理性。同時，在美洲許多地區，採購決策越來越注重價值主導，強調整體治療效果而非單純的器械單價。在歐洲、中東和非洲，一些地區的監管協調和集中採購為能夠證明其臨床表現穩定且供應鏈合規的製造商創造了機會。同時，各國報銷體系和臨床路徑的差異也要求製造商採取適應性強的打入市場策略。

領先製造商的策略行動和營運重點在於創新、證據產生和供應鏈韌性，以確保臨床應用。

輸尿管支架領域的主要企業正透過自主創新、策略合作和有針對性的收購相結合的方式，建構差異化的產品系列組合，並加速產品上市速度。投資重點通常包括可生物分解的材料平台、可降低黏附和感染風險的塗層表面，以及能夠提升患者舒適度和固定效果的設計。此外，各企業也透過研究者主導的臨床試驗、註冊研究合作以及真實世界證據項目，不斷增加臨床證據的積累，以支持監管申報和與支付方的溝通。這些努力通常輔以商業策略，例如整合臨床醫生培訓計畫、手術支援和全面的服務，旨在降低醫院系統的實施風險。

為製造商和醫療系統提供可操作的策略重點和營運措施，以加速臨床應用並建立具有韌性、以價值主導的經營模式。

產業領導者應優先採取一系列切實可行的措施，使研發、生產和商業性執行與當前的臨床和經濟需求保持一致。首先，將研發資源集中在能夠顯著減少併發症的材料和塗層，將增強對支付方和醫療服務提供者的價值提案。同時，對可靠的臨床證據和註冊登記進行同步投資，將加速產品在門診和住院環境中的推廣應用。其次，透過選擇性地進行近岸外包和利用檢驗的二手訊息，實現生產和採購網路的多元化，將降低關稅和物流風險，並確保醫療客戶的供應可靠性。第三，企業應完善商業模式，提供效能保證和服務包，整合醫療設備、培訓和後續支持，以支援全面的醫療保健合約和按績效付費的採購計畫。

採用透明的研究途徑，結合相關人員訪談、臨床文獻綜合、監管檢驗和資料三角驗證，以支持可操作的研究結果。

本執行摘要的研究整合了初步定性研究結果和全面的二手研究，以確保結果的平衡性和檢驗。初步研究包括對執業泌尿系統、門診和醫院採購人員、臨床試驗研究人員以及供應鏈高管進行結構化訪談，以提供關於醫療設備性能、採購因素和臨床工作流程的真實觀點。二級資訊來源資訊來源同行評審的臨床文獻、監管申報文件、材料科學出版物、公開的產品標籤和不利事件報告，這些資料用於對材料、塗層和器械結構進行技術評估。

對輸尿管支架系統的臨床、技術和運作趨勢進行簡明扼要的總結，闡明其競爭優勢和推廣路徑。

總而言之，輸尿管支架系統領域正經歷著材料創新、臨床實踐變革以及人們對價值和安全性日益成長的期望交匯融合的演變。生物可分解聚合物、工程金屬結構和抗菌表面技術的進步，在為臨床醫生拓展治療選擇的同時，也帶來了新的生產製造、監管和報銷方面的考量。同時，門診治療的日益普及、單次治療成本的壓力以及供應鏈的脆弱性，正迫使製造商將產品開發與可驗證的臨床療效和營運韌性相結合。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依材料分類的輸尿管支架系統市場

  • 可生物分解
    • PCL
    • PLGA
  • 金屬
    • 鎳鈦
    • 不銹鋼
  • 聚合物
    • PVC
    • 矽酮

9. 輸尿管支架系統市場（依產品類型分類）

  • 雙J
  • 共振金屬
  • 自膨脹

10. 輸尿管支架系統市場（依適應症分類）

  • 結石疾病
  • 堵塞
    • 良性
    • 惡性
  • 收縮

第11章 以最終用戶分類的輸尿管支架系統市場

  • 門診手術中心
    • 醫院所有
    • 醫生所有
  • 診所
  • 醫院
    • 私人的
    • 民眾

12. 輸尿管支架系統市場（依分銷管道分類）

  • 電子商務
    • B2B入口網站
    • B2C入口網站
  • 醫院銷售
  • 零售藥房
    • 鏈
    • 獨立的

13. 各地區輸尿管支架系統市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 輸尿管支架系統市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

15. 各國輸尿管支架系統市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

16. 美國輸尿管支架系統市場

第17章 中國輸尿管支架系統市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Allium Medical Solutions Ltd.
  • Amecath Medical Technologies
  • Applied Medical Resources Corporation
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Coloplast A/S
  • Conmed Corporation
  • Cook Medical LLC
  • EuroTec
  • JOLINE GmbH & Co. KG
  • Labotronix
  • Medi-Globe GmbH
  • Merit Medical Systems Inc.
  • Micro-Tech（Nanjing）Co., Ltd.
  • Olympus Corporation
  • Optimed Medizinische Instrumente GmbH
  • Porges SA
  • Rocamed SAS
  • Stryker Corporation
  • Taewoong Medical Co., Ltd.
  • Teleflex Incorporated
  • Urocare Products Inc.
  • Uromedica, Inc.
  • Urotech GmbH
  • Urovision GmbH
Product Code: MRR-C36616F699C1

The Ureteral Stent System Market was valued at USD 1.06 billion in 2025 and is projected to grow to USD 1.15 billion in 2026, with a CAGR of 8.16%, reaching USD 1.84 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.06 billion
Estimated Year [2026] USD 1.15 billion
Forecast Year [2032] USD 1.84 billion
CAGR (%) 8.16%

An authoritative orientation to clinical priorities, device evolution, and operational drivers shaping contemporary ureteral stent system decision-making

The ureteral stent system continues to play a pivotal role in urologic care by enabling drainage of the upper urinary tract across a wide spectrum of indications, including obstructive stone disease, malignant compression, and benign strictures. Technological progression over recent years has moved the field beyond simple polymer tubes toward devices that incorporate advanced materials, surface treatments, and geometry designed to improve patient comfort, reduce encrustation, and extend indwelling lifespans. Clinicians and health system leaders increasingly evaluate stent selection not only on immediate clinical performance but also on downstream impacts such as readmission rates, procedural repeat interventions, and total cost of care.

From a clinical perspective, the balance among ease of insertion, radiopacity, resistance to biofilm formation, and removal logistics remains the core determinant of device adoption. At the same time, the market environment is shaped by rising ambulatory procedures, payer scrutiny of device-related episode costs, and regulatory expectations for safety and post-market surveillance. Consequently, strategic planning for manufacturers, providers, and procurement organizations must incorporate both clinical evidence and operational levers to maintain alignment with evolving standards of care and patient experience priorities.

How advances in material science, antimicrobial technologies, and evolving care delivery models are redefining clinical practice and commercial strategy in ureteral stent systems

The landscape for ureteral stent systems is being reshaped by several transformative shifts that are simultaneously clinical, technological, and organizational. Advances in materials science, including biodegradable polymers and nitinol alloys with refined surface finishes, are creating new product categories that seek to reduce complications such as encrustation and migration. Parallel progress in drug-eluting coatings and antimicrobial surface technologies is addressing infection and biofilm risk, enabling clinicians to consider stent therapies across broader indications and longer indwelling times. Moreover, additive manufacturing and precision engineering have opened opportunities for more individualized stent geometries and patient-specific solutions, although regulatory and production scaling remain practical constraints.

Operationally, care delivery is migrating toward ambulatory settings where shorter procedural times and faster patient turnover are prioritized. This shift is supported by improvements in pain control protocols and device designs that facilitate easier placement and removal. Supply chain dynamics, including sourcing of specialty materials and manufacturing consolidation, are encouraging strategic partnerships and vertical integration among component suppliers, device manufacturers, and contract manufacturers. Together, these transformations are elevating the importance of R&D velocity, real-world outcome data, and collaborative commercialization strategies in determining which technologies achieve market traction.

Operational and strategic repercussions of new cumulative tariff measures on procurement, manufacturing resilience, and value-based contracting within the ureteral stent ecosystem

The implementation of new tariff measures in the United States has introduced a complex set of headwinds and strategic responses across the ureteral stent value chain. Import levies on key raw materials and finished components have increased landed costs for manufacturers that rely on global suppliers, particularly for specialty polymers and metal alloys. In response, many firms have initiated tactical actions including renegotiation of supply contracts, inventory optimization, and selective nearshoring of critical production inputs to reduce exposure to transoceanic tariff volatility. These moves, however, require upfront capital and time to validate quality systems and regulatory compliance for new manufacturing locations.

Beyond procurement, tariff-driven cost pressures are influencing pricing discussions with institutional buyers and payers. Health systems facing constrained budgets are scrutinizing total cost of care implications and may favor devices that demonstrably reduce downstream resource use, such as those that minimize reintervention. Consequently, manufacturers are adjusting commercial models to emphasize value articulation and to offer bundled solutions that align with provider incentives. In parallel, some innovators are accelerating domestic manufacturing and supply chain diversification to insulate distribution continuity and to meet procurement preferences for locally sourced medical devices.

Deep segmentation insights connecting end users, material innovation, device typologies, clinical indications, and distribution pathways to strategic commercialization decisions

A granular understanding of clinical and commercial segmentation is essential for navigating product development and go-to-market strategies in the ureteral stent domain. When examining end users, the market bifurcates across ambulatory surgical centers, clinics, and hospitals; within ambulatory surgical centers there are distinct dynamics between hospital-owned facilities and physician-owned centers, while hospitals themselves present differential procurement patterns across private and public institutions. From a materials perspective, product offerings are distinguished by biodegradable options such as polycaprolactone and PLGA, metal stents built from nickel-titanium and stainless steel alloys, and polymeric devices typically manufactured from PVC or silicone; each material family has tradeoffs in terms of biocompatibility, flexibility, radiopacity, and manufacturing complexity.

Product type segmentation includes classic double J configurations, resonance metallic constructions designed for long-term patency, and self-expanding models engineered to maintain luminal flow under extrinsic compression. Clinical indications further refine targeting, with stents deployed for calculi management, for relief of obstructions that may be benign or malignant in origin, and for treatment of strictures where dwell time and migration risk are critical considerations. Distribution channels span e-commerce platforms with B2B and B2C portals, direct hospital sales for institutional purchasing, and retail pharmacies that operate through chain and independent outlets; each channel imposes different logistics, contracting, and regulatory implications for manufacturers and distributors. Integrating these segmentation lenses supports prioritization of R&D investments, tailored clinical evidence generation, and differentiated commercial approaches aligned with the needs of specific end users and payers.

How regional regulatory environments, reimbursement dynamics, and care delivery trends across the Americas, Europe Middle East and Africa, and Asia Pacific shape adoption and access

Regional dynamics exert a pronounced influence on regulatory frameworks, reimbursement practices, and clinical adoption patterns for ureteral stent systems across global markets. In the Americas, diverse payer structures and a concentration of advanced tertiary centers drive demand for differentiated device features and evidence packages that justify higher unit costs when offset by reduced downstream interventions. Conversely, procurement in many parts of the region is increasingly guided by value-based purchasing decisions that emphasize total episode outcomes rather than device list price alone. In Europe, Middle East & Africa, regulatory harmonization efforts and centralized procurement in some jurisdictions create opportunities for manufacturers that can demonstrate consistent clinical performance and compliant supply chains, while country-level heterogeneity in reimbursement and clinical pathways requires adaptive market entry strategies.

In the Asia-Pacific region, rapid expansion of ambulatory services and rising investments in minimally invasive urology support accelerated uptake of innovative stent designs, but pricing sensitivity and fragmented distribution networks necessitate flexible commercialization models. Local manufacturing capabilities and partnerships with regional distributors are often critical for scaling access and meeting regulatory timelines. Across all regions, differences in clinical practice patterns, incidence of stone disease, and infrastructure for follow-up care shape the real-world performance expectations for stents, making region-specific evidence generation and tailored sales approaches vital for long-term adoption.

Strategic behaviors and operational priorities of prominent manufacturers focusing on innovation, evidence generation, and supply chain resilience to secure clinical uptake

Leading organizations in the ureteral stent sector are pursuing a mix of organic innovation, strategic collaborations, and targeted acquisitions to build differentiated portfolios and to accelerate time to market. Investment priorities commonly include biodegradable material platforms, coated surfaces that reduce encrustation and infection risk, and engineered geometries that improve patient comfort and anchoring. Companies are also strengthening clinical evidence generation through investigator-initiated studies, registry partnerships, and real-world evidence programs to support both regulatory filings and payer discussions. These efforts are often complemented by commercial strategies that integrate training programs for clinicians, procedural support, and bundled service offerings intended to de-risk adoption for hospital systems.

Operationally, market leaders are optimizing manufacturing footprints and supply chain resilience to ensure continuity in the face of global disruptions and policy shifts. Collaboration with contract manufacturers and strategic suppliers enables scalable production while maintaining quality oversight, whereas forward-looking players are exploring nearshore capacity to reduce lead times and tariff exposure. On the commercial front, organizations are diversifying distribution models to include direct sales to hospitals, digital channels for physician engagement, and partnerships with retail chains and pharmacy networks to broaden patient access. Collectively, these approaches reflect a maturation of industry tactics from single-product promotion to integrated solutions that address clinical outcomes, economics, and lifecycle support.

Actionable strategic priorities and operational measures for manufacturers and health systems to accelerate clinical adoption and build resilient, value-driven business models

Industry leaders should prioritize a set of actionable measures that align R&D, manufacturing, and commercial execution to prevailing clinical and economic demands. First, focusing development resources on materials and coatings that demonstrably reduce complications will strengthen value propositions to payers and providers, while parallel investments in robust clinical evidence and registries will accelerate acceptance in both ambulatory and inpatient settings. Second, diversifying manufacturing and supplier networks through selective nearshoring and validated secondary sources will limit tariff and logistics exposure and preserve delivery reliability for institutional customers. Third, companies should refine commercial models to align with bundled care arrangements and outcomes-based purchasing, offering performance guarantees or service packages that integrate device, training, and follow-up support.

Additionally, firms should develop differentiated channel strategies that recognize the distinct needs of hospital procurement, ambulatory centers, and pharmacy networks, while leveraging digital engagement and telehealth integration to support pre- and post-procedural care. Collaborative partnerships with clinical leaders and health systems can yield real-world data and facilitate guideline inclusion. Finally, operational investments in regulatory strategy, quality systems, and post-market surveillance will expedite approvals in multiple jurisdictions and mitigate compliance risk, enabling scalable adoption across diverse healthcare environments.

Transparent research approach combining stakeholder interviews, clinical literature synthesis, regulatory verification, and data triangulation to underpin actionable insights

The research underpinning this executive summary synthesizes primary qualitative insights and comprehensive secondary analysis to ensure balanced and validated findings. Primary research included structured interviews with practicing urologists, procurement leaders in ambulatory and hospital settings, clinical trial investigators, and supply chain executives, providing real-world perspectives on device performance, procurement drivers, and clinical workflow considerations. Secondary sources comprised peer-reviewed clinical literature, regulatory filings, material science publications, and publicly available product labeling and adverse event reports; these sources informed technical assessments of materials, coatings, and device architectures.

Data triangulation techniques were applied to reconcile potential discrepancies across sources, and evidence weighting prioritized high-quality clinical data and stakeholder consensus where available. Quality assurance steps included cross-checking regulatory status and approval timelines, validating manufacturing locations and capabilities through supplier disclosures, and verifying distribution channel characteristics via trade publications and health system procurement policies. Throughout the research process, attention was paid to transparency in data sourcing and clarity in assumptions to support robust strategic interpretation without reliance on proprietary market sizing projections.

Concise synthesis of clinical, technological, and operational trends defining competitive advantage and adoption pathways in ureteral stent systems

In summary, the ureteral stent system landscape is evolving at the intersection of material innovation, shifting care settings, and heightened expectations for value and safety. Advances in biodegradable polymers, engineered metallic designs, and antimicrobial surface technologies are expanding therapeutic choices for clinicians while introducing new considerations for manufacturing, regulation, and reimbursement. At the same time, the growing role of ambulatory care, pressure on episode costs, and supply chain sensitivities require manufacturers to align product development with demonstrable clinical outcomes and operational resilience.

Looking ahead, success in this sector will favor organizations that can combine technical differentiation with rigorous clinical evidence, flexible manufacturing strategies, and commercial models that support value-based adoption. Health systems and clinicians will increasingly select stent solutions that reduce reintervention risk, simplify care pathways, and integrate with broader urologic treatment strategies. By focusing on these integrated priorities, stakeholders across the value chain can better navigate the complexities of device selection, procurement, and long-term patient management.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Ureteral Stent System Market, by Material

  • 8.1. Biodegradable
    • 8.1.1. Pcl
    • 8.1.2. Plga
  • 8.2. Metal
    • 8.2.1. Nickel Titanium
    • 8.2.2. Stainless Steel
  • 8.3. Polymer
    • 8.3.1. Pvc
    • 8.3.2. Silicone

9. Ureteral Stent System Market, by Product Type

  • 9.1. Double J
  • 9.2. Resonance Metallic
  • 9.3. Self Expanding

10. Ureteral Stent System Market, by Indication

  • 10.1. Calculi
  • 10.2. Obstruction
    • 10.2.1. Benign
    • 10.2.2. Malignant
  • 10.3. Stricture

11. Ureteral Stent System Market, by End User

  • 11.1. Ambulatory Surgical Centers
    • 11.1.1. Hospital Owned
    • 11.1.2. Physician Owned
  • 11.2. Clinics
  • 11.3. Hospitals
    • 11.3.1. Private
    • 11.3.2. Public

12. Ureteral Stent System Market, by Distribution Channel

  • 12.1. E-Commerce
    • 12.1.1. B2B Portals
    • 12.1.2. B2C Portals
  • 12.2. Hospital Sales
  • 12.3. Retail Pharmacies
    • 12.3.1. Chain
    • 12.3.2. Independent

13. Ureteral Stent System Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Ureteral Stent System Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Ureteral Stent System Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Ureteral Stent System Market

17. China Ureteral Stent System Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Allium Medical Solutions Ltd.
  • 18.6. Amecath Medical Technologies
  • 18.7. Applied Medical Resources Corporation
  • 18.8. B. Braun Melsungen AG
  • 18.9. Becton, Dickinson and Company
  • 18.10. Boston Scientific Corporation
  • 18.11. Coloplast A/S
  • 18.12. Conmed Corporation
  • 18.13. Cook Medical LLC
  • 18.14. EuroTec
  • 18.15. JOLINE GmbH & Co. KG
  • 18.16. Labotronix
  • 18.17. Medi-Globe GmbH
  • 18.18. Merit Medical Systems Inc.
  • 18.19. Micro-Tech (Nanjing) Co., Ltd.
  • 18.20. Olympus Corporation
  • 18.21. Optimed Medizinische Instrumente GmbH
  • 18.22. Porges S.A.
  • 18.23. Rocamed SAS
  • 18.24. Stryker Corporation
  • 18.25. Taewoong Medical Co., Ltd.
  • 18.26. Teleflex Incorporated
  • 18.27. Urocare Products Inc.
  • 18.28. Uromedica, Inc.
  • 18.29. Urotech GmbH
  • 18.30. Urovision GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL URETERAL STENT SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL URETERAL STENT SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES URETERAL STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA URETERAL STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PCL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PCL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PCL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PLGA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PLGA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PLGA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY NICKEL TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY NICKEL TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY NICKEL TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PVC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PVC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PVC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY DOUBLE J, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY DOUBLE J, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY DOUBLE J, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY RESONANCE METALLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY RESONANCE METALLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY RESONANCE METALLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY SELF EXPANDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY SELF EXPANDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY SELF EXPANDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY CALCULI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY CALCULI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY CALCULI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY BENIGN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY BENIGN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY BENIGN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY MALIGNANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY MALIGNANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY MALIGNANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY STRICTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY STRICTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY STRICTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITAL OWNED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITAL OWNED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITAL OWNED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PHYSICIAN OWNED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PHYSICIAN OWNED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PHYSICIAN OWNED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PUBLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY B2B PORTALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY B2B PORTALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY B2B PORTALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY B2C PORTALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY B2C PORTALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY B2C PORTALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITAL SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITAL SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITAL SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY CHAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY CHAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY CHAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY INDEPENDENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY INDEPENDENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY INDEPENDENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS URETERAL STENT SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS URETERAL STENT SYSTEM MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE URETERAL STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE URETERAL STENT SYSTEM MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST URETERAL STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST URETERAL STENT SYSTEM MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC URETERAL STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC URETERAL STENT SYSTEM MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 221. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN URETERAL STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN URETERAL STENT SYSTEM MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 236. GCC URETERAL STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. GCC URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 238. GCC URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, 2018-2032 (USD MILLION)
  • TABLE 239. GCC URETERAL STENT SYSTEM MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 240. GCC URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 241. GCC URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. GCC URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 243. GCC URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 244. GCC URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. GCC URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 246. GCC URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 247. GCC URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 248. GCC URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 249. GCC URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPEAN UNION URETERAL STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPEAN UNION URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION URETERAL STENT SYSTEM MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPEAN UNION URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPEAN UNION URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 264. BRICS URETERAL STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 265. BRICS URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 266. BRICS URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS URETERAL STENT SYSTEM MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 269. BRICS URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 272. BRICS URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 273. BRICS URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 274. BRICS URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 275. BRICS URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 276. BRICS URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 277. BRICS URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 278. G7 URETERAL STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 279. G7 URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 280. G7 URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, 2018-2032 (USD MILLION)
  • TABLE 281. G7 URETERAL STENT SYSTEM MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 282. G7 URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 283. G7 URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. G7 URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 285. G7 URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 286. G7 URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 287. G7 URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 288. G7 URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 289. G7 URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 290. G7 URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 291. G7 URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 292. NATO URETERAL STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 293. NATO URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 294. NATO URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, 2018-2032 (USD MILLION)
  • TABLE 295. NATO URETERAL STENT SYSTEM MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 296. NATO URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 297. NATO URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 298. NATO URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 299. NATO URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 300. NATO URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 301. NATO URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 302. NATO URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 303. NATO URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 304. NATO URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 305. NATO URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 306. GLOBAL URETERAL STENT SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED STATES URETERAL STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED STATES URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED STATES URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED STATES URETERAL STENT SYSTEM MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED STATES URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED STATES URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED STATES URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED STATES URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 315. UNITED STATES URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 316. UNITED STATES URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 317. UNITED STATES URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 318. UNITED STATES URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 319. UNITED STATES URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 320. UNITED STATES URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
  • TABLE 321. CHINA URETERAL STENT SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 322. CHINA URETERAL STENT SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 323. CHINA URETERAL STENT SYSTEM MARKET SIZE, BY BIODEGRADABLE, 2018-2032 (USD MILLION)
  • TABLE 324. CHINA URETERAL STENT SYSTEM MARKET SIZE, BY METAL, 2018-2032 (USD MILLION)
  • TABLE 325. CHINA URETERAL STENT SYSTEM MARKET SIZE, BY POLYMER, 2018-2032 (USD MILLION)
  • TABLE 326. CHINA URETERAL STENT SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 327. CHINA URETERAL STENT SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 328. CHINA URETERAL STENT SYSTEM MARKET SIZE, BY OBSTRUCTION, 2018-2032 (USD MILLION)
  • TABLE 329. CHINA URETERAL STENT SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 330. CHINA URETERAL STENT SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 331. CHINA URETERAL STENT SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 332. CHINA URETERAL STENT SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 333. CHINA URETERAL STENT SYSTEM MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 334. CHINA URETERAL STENT SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)